Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Switzerland

European Research Council grant · Running

CAPTOMER Selective isolation of biopharmaceuticals with fluid zwitterionic polymeric coacervates

Coordinator
Eidgenoessische Technische Hochschule Zuerich, Switzerland
Runs
1 January 2026 to 30 June 2027
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101248663

What the project is doing

In the project's own words, from its summary on CORDIS.

Gene therapy and RNA-based therapeutics hold significant promise for treating a range of debilitating disorders. A key challenge for these therapies is the effective targeted delivery, which relies on nanovehicles to ensure the stability of the delicate nucleic acids involved. Biogenic nanoparticles, such as adeno-associated viruses (AAVs), are becoming increasingly promising for these applications, with some AAV-based therapies already receiving regulatory approval.

However, maintaining the physicochemical properties essential for the efficacy and safety of these products presents significant challenges, particularly due to their complex manufacturing processes, which often result in a high degree of impurities or perturbations in their structures. Traditional bioseparation methods, such as chromatography, struggle to efficiently isolate these nanoparticles without compromising their quality.

To address these issues, this project proposes a novel isolation technique for AAVs using functionalized, programmable liquid-like coacervates formed from zwitterionic polymers. Previous applications on extracellular vesicles demonstrated significant improvements in purity, yield, and processing time compared to conventional methods. The liquid nature of coacervates preserves particle integrity during isolation while their anti-fouling properties enhance specificity in capturing target molecules.

This scalable approach integrates the benefits of existing purification methods, offering a gentler, efficient, and simple solution for bioseparation. Building on the success of the Consolidator ERC-funded ""VELCROproteins"" project, this initiative translates insights obtained from biological condensate research to design coacervates with tunable properties for diverse biotechnological applications, particularly in the healthcare sector.

The project aims to establish a new purification processes for crucial nanomaterials, paving the way for advanced therapeutic strategies.""

Topics

Who is involved

OrganisationCityCountryRole
Eidgenoessische Technische Hochschule ZuerichZuerichSwitzerlandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI